Retraction
MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells
Paper Information
Record ID:
32384
Journal:
Publication Date:
November 07, 2019
Retraction Date:
August 12, 2021
(4.3 years years ago)
Subjects:
Institutions:
- Department of Obstetrics and Gynecology, Lishui Hospital of Traditional Chinese Medicine, Lishui, Zhejiang, China
- Department of Gynecology, Xuzhou Hospital of Traditional Chinese Medicine, Xuzhou, Jiangsu, China
- Department of Cardiology, Lishui Hospital of Traditional Chinese Medicine, Lishui, Zhejiang, China
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
- Department of Gynecology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Mary Ann Liebert
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reason:
Nature of Retraction:
Retraction
Retraction Notice:
10.1089/cbr.2019.2858.retractCitations (19)
19
Total Citations10
Post-Retraction(52.6%)
9
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
6
Within 1 year
0
After 2+ years
688
Days since retraction (latest)
Matrine inhibits miR-181a-mediated chemoresistance in rectal cancer
Wenzhe Gu, Zhengjie Shen
Materials Express
Published: Jul 2023
688 days after retraction
microRNA-660 Enhances Cisplatin Sensitivity via Decreasing SATB2 Expression in Lung Adenocarcinoma
Ziyao Wang, Lingxuan Zhou, Bisong Chen et al. (10 authors)
Genes
Open Access
Published: Apr 2023
4 citations
4 citations
610 days after retraction
Screening and identification of miR-181a-5p in oral squamous cell carcinoma and functional verification in vivo and in vitro
Guoqiang Xu, Yi‐Yan Yang, Junting Yang et al. (12 authors)
BMC Cancer
Open Access
Published: Feb 2023
12 citations
12 citations
554 days after retraction
Osteopontin and Cancer: Insights into Its Role in Drug Resistance
Chengcheng Hao, Jane Lane, Wen G. Jiang
Biomedicines
Open Access
Published: Jan 2023
21 citations
21 citations
518 days after retraction
Biological and Clinicopathological Characteristics of OPN in Cervical Cancers
Shuhang Qin, Li Yi, Yanchun Liang et al. (10 authors)
Frontiers in Genetics
Open Access
Published: May 2022
281 days after retraction
SERS Immunosensor Based on High-Density “Hotspots” Au@SiO<sub>2</sub> Array Substrate and Au-Ag Nanoshells Probes for Ultrasensitive Detection of Dual Biomarkers in the Cervical Cancer Serum
Menglin Ran, Qilong Song, Yifan Liu et al. (6 authors)
NANO
Published: Mar 2022
6 citations
6 citations
201 days after retraction
MicroRNA-92a-3p Enhances Cisplatin Resistance by Regulating Krüppel-Like Factor 4-Mediated Cell Apoptosis and Epithelial-to-Mesenchymal Transition in Cervical Cancer
Jing Yang, Jing Hai, Xuecai Dong et al. (5 authors)
Frontiers in Pharmacology
Open Access
Published: Jan 2022
7 citations
7 citations
155 days after retraction
Long Noncoding RNA Brain Cytoplasmic RNA 1 Induces Cisplatin-Resistance of Cervical Cancer Cells by Sponging MicroRNA-330-5p and Upregulating High-Mobility Group Box 3
Dan Sun, Rui Cao, Lu Han et al. (7 authors)
Gynecologic and Obstetric Investigation
Published: Jan 2022
5 citations
5 citations
142 days after retraction
Increased PD-L1 Expression in Acquired Cisplatin-Resistant Lung Cancer Cells via Mir-181a
Yingying Chen, Wei Song, Yuan Gao et al. (5 authors)
The Tohoku Journal of Experimental Medicine
Open Access
Published: Jan 2022
9 citations
9 citations
142 days after retraction
Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma
Xili Jiang, Wei Zhang, Lifeng Li et al. (4 authors)
Pathology & Oncology Research
Open Access
Published: Oct 2021
3 citations
3 citations
68 days after retraction
Role of miRNAs in cervical cancer: A comprehensive novel approach from pathogenesis to therapy
Mohammad Abbas, Abbas Mehdi, Faizan Haider Khan et al. (10 authors)
Journal of Gynecology Obstetrics and Human Reproduction
Published: May 2021
13 citations
13 citations
97 days before retraction
MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells
Yongqian Xu, Yujie Zheng, Yan Duan et al. (5 authors)
Oncology Letters
Open Access
Published: Mar 2021
4 citations
4 citations
147 days before retraction
The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
Rina Masadah, Syahrul Rauf, Muhammad Yogi Pratama et al. (5 authors)
Cancers
Open Access
Published: Mar 2021
35 citations
35 citations
156 days before retraction
Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
Asal Jalal Abadi, Ali Zarrabi, Mohammad Gholami et al. (11 authors)
Biomolecules
Open Access
Published: Feb 2021
65 citations
65 citations
175 days before retraction
[Effect of small interfering RNA-mediated BIRC6 silencing on apoptosis and autophagy of renal cancer 786-O cells].
Kaihua Zhong, Chen Dong, Zhiming Wu et al. (7 authors)
Nanfang Yike Daxue xuebao
Published: Nov 2020
2 citations
2 citations
255 days before retraction
Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives
Ebrahim Rahmani Moghadam, Hui Li Ang, Sholeh Etehad Asnaf et al. (10 authors)
Biomolecules
Open Access
Published: Sep 2020
61 citations
61 citations
319 days before retraction
MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi et al. (7 authors)
Life Sciences
Published: Jun 2020
30 citations
30 citations
418 days before retraction
The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines
Dominika Kaźmierczak, Karol Jopek, Karolina Sterzyńska et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Apr 2020
24 citations
24 citations
490 days before retraction
The significance of microRNA genes expression in ovarian cancer cell lines resistant to cytotoxic drugs
Dominika Kaźmierczak, Karol Jopek, Karolina Sterzyńska et al. (5 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Dec 2019
617 days before retraction
Quick Stats
Total Citations:
19
Years Since Retraction:
4.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025